Source:http://linkedlifedata.com/resource/pubmed/id/10894753
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-8-9
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1087-0571
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-8
|
pubmed:dateRevised |
2011-5-23
|
pubmed:meshHeading |
pubmed-meshheading:10894753-Automation,
pubmed-meshheading:10894753-Benchmarking,
pubmed-meshheading:10894753-Capital Expenditures,
pubmed-meshheading:10894753-Chemistry, Pharmaceutical,
pubmed-meshheading:10894753-Drug Industry,
pubmed-meshheading:10894753-Intellectual Property,
pubmed-meshheading:10894753-Outsourced Services
|
pubmed:year |
2000
|
pubmed:articleTitle |
To outsource in lead discovery: the devil or the deep blue sea?
|
pubmed:affiliation |
EVOTEC BioSystems AG, Hamburg, Germany. Tom.mander@evotec.de
|
pubmed:publicationType |
Journal Article
|